| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/14/2004 | EP1435944A1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 07/14/2004 | EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435936A1 5'-carbamoyl-1,1-biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435935A2 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435925A2 Gap junctions and edhf |
| 07/14/2004 | EP1435924A2 Therapeutic composition and use |
| 07/14/2004 | EP1435922A1 Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent |
| 07/14/2004 | EP1435917A1 Solid pharmaceutical formulation for a piperazine urea derivative |
| 07/14/2004 | EP1435910A1 Novel cyclosporin analog microemulsion preconcentrates |
| 07/14/2004 | EP1435906A2 Method for producing biologically active products |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1365760A4 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/14/2004 | EP1315793A4 Methods for culturing human lung mast cells and uses thereof |
| 07/14/2004 | EP1248802B1 Soluble ctla4 mutant molecules and uses thereof |
| 07/14/2004 | EP1248630B1 Use of a dermatological composition containing oligosaccharides for the treatment of skin diseases |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1210350B1 Water soluble sdz-rad esters |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | EP1077940B1 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 07/14/2004 | EP1037887B1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
| 07/14/2004 | EP1002792B1 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same |
| 07/14/2004 | EP0961775B1 Purine l-nucleosides, analogs and uses thereof |
| 07/14/2004 | EP0824588B1 Il-6 activity inhibitor |
| 07/14/2004 | EP0754227B1 Chimeric complement inhibitor proteins |
| 07/14/2004 | CN1513000A Anti-osteopontin antibody and use thereof |
| 07/14/2004 | CN1512993A Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases |
| 07/14/2004 | CN1512992A Novel adenine derivatives |
| 07/14/2004 | CN1512987A Novel 1H-indazole compound |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512895A Use of polyclonal immunoglobulins |
| 07/14/2004 | CN1512894A Monocyte specific particulate delivery vehicle |
| 07/14/2004 | CN1512890A HCG formulation |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1511958A System of T cell surface antigen peptide screening human tissue compatibility antigen (HLA) and its application in producing MHC-antigen peptide polymer |
| 07/14/2004 | CN1511838A Triptolide alcohol derivative and its use |
| 07/14/2004 | CN1511837A Intermediate for heterocyclic compound in preparing rotamase inhibitor |
| 07/14/2004 | CN1511834A Immune regulation and biological therapeutic function of benzo-isoselenazole derivatives |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1511519A Therapy for immunological disease of type 2 T auxiliary cell mediated |
| 07/14/2004 | CN1157226C Stable alpha-interferon preparation |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/14/2004 | CN1157221C Health compsn. |
| 07/14/2004 | CN1157195C Soft capsule of superfine compound pearl powder and its preparing process |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762205 Phenyl sulfamate derivatives |
| 07/13/2004 | US6762200 Phospholipase inhibitors |
| 07/13/2004 | US6762195 Treating diseases mediated by tumor necrosis factor; inhibit angiogenesis and treatment of cancer, inflammatory, and autoimmune diseases |
| 07/13/2004 | US6762191 Therapeutic compounds |
| 07/13/2004 | US6762186 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762165 Snail venom; muscular disorders, central nervous system disorders, cardiovascular disorders |
| 07/13/2004 | US6762164 Use of 3-position cyclosporin derivatives for hair growth |
| 07/13/2004 | US6762021 Method for diagnosis of crohn's disease |
| 07/13/2004 | US6761900 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
| 07/13/2004 | US6761893 Modified vaccinia ankara virus variant |
| 07/13/2004 | US6761889 Adjusting affinity of fab 27/26 fragments/polypeptides generating improved ragweed-induced histamine release inhibition; bronchodilator agents |
| 07/13/2004 | CA2301267C Method of enhancing bioavailability of fexofenadine and its derivatives |
| 07/13/2004 | CA2268684C Process for alkylating hindered sulfonamides |
| 07/13/2004 | CA2163212C Therapeutic compounds |
| 07/13/2004 | CA2118859C Enantiomers of 1-[(4-chlorophenyl)-phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine |
| 07/08/2004 | WO2004056875A1 Antibodies against pd-1 and uses therefor |
| 07/08/2004 | WO2004056873A1 Increase of the immune response by substances influencing the function of natural killer cells |
| 07/08/2004 | WO2004056868A2 Nf-hev compositions and methods of use |
| 07/08/2004 | WO2004056823A1 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS |
| 07/08/2004 | WO2004056783A1 Process for the preparation of an essentially pure polymorph of an n-pyrazolyl-n'-naphthyl-urea |
| 07/08/2004 | WO2004056770A2 Piperidine derivatives useful as ccr5 antagonists |
| 07/08/2004 | WO2004056747A1 Dhodh-inhibitors and method for their identification |
| 07/08/2004 | WO2004056746A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/08/2004 | WO2004056376A1 Pharmaceutical formulations containing nitrate |
| 07/08/2004 | WO2004042039B1 Induction of ctla-4 upregulation in t lymphocytes |
| 07/08/2004 | WO2004019979A3 Vaccine comprising il-13 and an adjuvant |
| 07/08/2004 | WO2004019975A3 Il-14 vaccine for the treatment of asthma and atopic disorders |
| 07/08/2004 | WO2004017920A3 Novel biphenyl and biphenyl-like cannabinoids |
| 07/08/2004 | WO2004012653A3 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 07/08/2004 | WO2004006853A3 Treatment and prophylaxis with 4-1bb-binding agents |
| 07/08/2004 | WO2003105771A3 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/08/2004 | WO2003103663A3 Substituted pyrrolines as kinase inhibitors |
| 07/08/2004 | WO2003097598A8 Compound exhibiting pgd 2 receptor antagonism |
| 07/08/2004 | WO2003090676A3 Immunogenic agent therapy using plasmapheresis or exchange transfusion |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | US20040133356 Three-dimensional model of a Fc region of an IgE antibody and uses thereof |
| 07/08/2004 | US20040132988 Immunoeffector compounds |
| 07/08/2004 | US20040132979 Using chromatographic support to isolate and enhance fluid fraction for therapeutic immunoglobulins; vaccines; immunotherapy |
| 07/08/2004 | US20040132830 Antiproliferative agents; anticancer agents; antiinflammatory agents; autoimmune diseases |
| 07/08/2004 | US20040132822 Crystalline solid form of (2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132804 1-aminoindane derivatives, e.g., 1-(cyclopentylcarbonylamino)-5-(4-cyclopropyl-2-(phenylsulfonyl)phenylsulfonyl)indane; exhibit anti-inflammatory and immunomodulatory activity |
| 07/08/2004 | US20040132788 thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives; treating neurodegenerative disorders or pain. |
| 07/08/2004 | US20040132784 1-optionally protected hydroxy-2-aminoalkylaryl compounds, especially in which the amino and hydroxy groups are joined by a carbonyl to form an oxazolidinone ring; immunosuppressants |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132772 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 07/08/2004 | US20040132762 Sulfonamide and sulfamide substituted imidazoquinolines |
| 07/08/2004 | US20040132748 Novel adenne derivatives |
| 07/08/2004 | US20040132744 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |